Berkeley Appeals PTAB Ruling In MIT, Broad CRISPR Dispute
Law360, Los Angeles (April 13, 2017, 7:43 PM EDT) -- Researchers from the University of California, Berkeley and the University of Vienna on Wednesday appealed a Patent Trial and Appeal Board decision finding no overlap between their CRISPR patents and those of the Massachusetts-based Broad Institute, furthering the IP battle between elite teams of scientists over the revolutionary gene-editing technology.
The Berkeley team and the Massachusetts team — consisting of the Broad Institute, the Massachusetts Institute of Technology and Harvard University — had each argued to the PTAB that they were the first to invent the efficient CRISPR-Cas9 technology, a groundbreaking method of genome editing that could aid in the treatment of genetic diseases and...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!